331 related articles for article (PubMed ID: 11828012)
41. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
42. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract][Full Text] [Related]
43. Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.
Matheson EC; Hall AG
Adv Exp Med Biol; 1999; 457():579-83. PubMed ID: 10500837
[TBL] [Abstract][Full Text] [Related]
44. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
[TBL] [Abstract][Full Text] [Related]
46. [Gastric cancer and microsatellite instability].
Itoh F; Yamamoto H; Horiuchi S; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2002 Sep; 99(9):1043-9. PubMed ID: 12355890
[No Abstract] [Full Text] [Related]
47. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
48. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
49. Meiotic arrest and aneuploidy in MLH3-deficient mice.
Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
[TBL] [Abstract][Full Text] [Related]
50. Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements.
Indraccolo S; Minuzzo S; Nicoletti L; Cretella E; Simon M; Papakonstantinou G; Hehlmann R; Mion M; Bertorelle R; Roganovic J; Chieco-Bianchi L
Blood; 1999 Oct; 94(7):2424-32. PubMed ID: 10498615
[TBL] [Abstract][Full Text] [Related]
51. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
52. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
Clay MR; Allison KH; Folkins AK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
[TBL] [Abstract][Full Text] [Related]
53. MutLĪ± heterodimers modify the molecular phenotype of Friedreich ataxia.
Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
[TBL] [Abstract][Full Text] [Related]
54. Effects of sequence divergence on the efficiency of extrachromosomal recombination in mismatch repair proficient and deficient mammalian cell lines.
Villemure JF; Belmaaza A
Somat Cell Mol Genet; 1999 Mar; 25(2):79-90. PubMed ID: 11225058
[TBL] [Abstract][Full Text] [Related]
55. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
56. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
57. Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification.
Li Z; Scherer SJ; Ronai D; Iglesias-Ussel MD; Peled JU; Bardwell PD; Zhuang M; Lee K; Martin A; Edelmann W; Scharff MD
J Exp Med; 2004 Jul; 200(1):47-59. PubMed ID: 15238604
[TBL] [Abstract][Full Text] [Related]
58. The ATPase activity of MLH1 is required to orchestrate DNA double-strand breaks and end processing during class switch recombination.
Chahwan R; van Oers JM; Avdievich E; Zhao C; Edelmann W; Scharff MD; Roa S
J Exp Med; 2012 Apr; 209(4):671-8. PubMed ID: 22451719
[TBL] [Abstract][Full Text] [Related]
59. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
Cannavo E; Gerrits B; Marra G; Schlapbach R; Jiricny J
J Biol Chem; 2007 Feb; 282(5):2976-86. PubMed ID: 17148452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
